# Cardiovascular Disease Risk #
:::warning
Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.
:::
[](https://cardio-balance-ph.store-best.net)
<div style="height:500px;"></div>
## The mortality due to diseases of the circulatory System ##
<div class="alert alert-info" role="alert">
Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan.
</div>
The hazards and risk factors:
Cardiovascular disease: risks and risk factors
Cardiovascular disease (CVD) is one of the most important health challenges of the 21st century. This century. According to the data of the world health organization (WHO), the world's leading cause of death and responsible for annually, approximately 17.9 million deaths, which equates to just under 32% of all global deaths.
Definition and main forms
Heart disease is a group of diseases that involve the heart and the vascular system. Among the most common forms:
Coronary heart disease (CHD): due to narrowing of the coronary arteries causes, leads to myocardial infarction.
Stroke (apoplexy): by thrombus or bleeding in the brain triggered.
High blood pressure (hypertension): durable high blood pressure, heart and kidney burden.
Congestive heart failure: a functional disorder of the heart, and it will not longer be able to adequately pump blood.
Arrhythmias: irregular heart rhythms, which can lead to life-threatening conditions.
Dangers and consequences
The main risk of CVD is in their often slow course. Many patients are aware of their disease for a long time not aware of it until it comes to acute events such as a heart attack or stroke. Long-term CVD can lead to serious complications:
Impairment of quality of life due to limitation of physical performance.
Development of organ damage (renal failure, dementia, seizures after repeated micro-percussion).
Increased risk for sudden cardiac death.
High costs for the healthcare system through long-term care and Rehabilitation.
Risk factors
A number of modifiable and non-modifiable factors increases the risk for CVD:
Non-modifiable factors:
Age (50 years increases the risk significantly).
Gender (men are up to 60. Age at greater risk).
Genetic predisposition (family history of early heart attacks).
Modifiable Factors:
Smoking (increases the risk of myocardial Infarction in the 2-to 4-fold).
Overweight and obesity (high BMI ≥30 kg/m
2
).
Lack of exercise (less than 150 minutes of moderate physical activity per week).
Unbalanced diet (high in salt, sugar and fat content).
Chronic Stress and lack of sleep.
Diabetes mellitus (increased vascular risk).
Hyperlipidemia (elevated cholesterol levels, especially LDL).
Prevention and conclusion
The sufficient prevention of cardiovascular disease requires a holistic approach: regular medical check-UPS, healthy lifestyle, education of the population and political measures for the reduction of risk factors (e.g. tobacco control laws, a sugar tax). Due to early detection and targeted intervention, the individual and societal risk can be significantly reduced.
The fight against CVD is not only a medical but also a social and political task that requires long-term strategies.
> Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate
<a href="https://dok.kompot.si/s/2fND3hbT_V">Cardiovascular Disease Risk</a>
Ginagamit ito bilang biologically active na pampadagdag sa pagkain - dagdag na pinagmumulan ng mga bitamina - B2, B6, C, mga organikong asido - mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. <a href="http://dientrotiendathc.com/media/ftp/urgent-diseases-of-the-circulatory-system.xml">Cardiovascular Disease Risk</a>
## Results Of Cardiovascular Diseases ##
Cardiovascular diseases: results and challenges for health policy
Cardiovascular diseases remain a major cause of morbidity and mortality in Germany and around the world. According to the latest results of the Robert Koch Institute (RKI) are caused in approximately one-third of deaths in Germany to diseases of the cardiovascular system. These Figures clearly show that the control of these diseases remains one of the most important health policy tasks.
Current statistics and research findings
The latest studies reveal several important Trends:
Frequency: About 20% of adults in Germany suffer from high blood pressure, one of the main causes of heart attacks and strokes.
Age distribution: Although cardiovascular disease is more likely to occur in the elderly, is increasing its incidence in younger adults (35-45 years).
Risk factors: Obesity, lack of physical activity, Smoking, and unhealthy diet are the main risk factors. According to a study by the German heart research center, 60% of cases are due to these changeable factors.
Regional differences: In the Eastern States, the Rate of cardiovascular disease is slightly higher than in the West, which may be associated with socio-economic factors.
Progress in diagnostics and therapy
Despite the sobering statistics, there are also positive developments. Medical research has made in the last few years, great progress:
New drugs for lowering blood pressure and cholesterol levels increase the quality of life and life expectancy of the patients.
Early detection through regular health examinations (e.g., ECG, blood pressure measurement) allows early Intervention.
Advances in minimally invasive surgery (e.g., Stent Implantation), reduce the rate of complications and recovery time after surgery.
Prevention as the key strategy
The main findings of the current findings is that prevention plays a Central role. Health campaigns that promote a healthier way of life, are of crucial importance:
Education about healthy diet (more fruits, vegetables, less salt and saturated fatty acids).
Promotion of regular physical activity (at least 150 minutes of moderate load per week).
Support for smoke quitting.
Awareness of the importance of regular medical examinations, especially for people with a family history.
Conclusion
The results for the dissemination and treatment of cardiovascular diseases show an ambiguous image. While the research is in progress and the therapy options are better, the high prevalence of these diseases is a great challenge. The solution lies in a double approach: on the one hand, in the further improvement of medical care and on the other hand, in a more intensive prevention work on a societal level. Only in this way the burden of cardiovascular can be diseases in the long term, to reduce the health of the population in a sustainable way to improve.
<a href="http://igniteideascorp.com/userfiles/cardiovascular-problems.xml">Cardiovascular Disease Risk</a> ** Cardiovascular Disease Risk **.
The mortality due to diseases of the cardiovascular system
ErHANDLUNG OF CARDIOVASCULAR DISEASE (CVD) is one of the most important health challenges of the modern society. According to the data of the world health organization (WHO), diseases of the circulatory system are the leading cause of death worldwide and cause a year, approximately 17.9 million deaths, equivalent to approximately 32% of all deaths globally.
Epidemiological situation in Germany
In Germany, statistical surveys show that CVD is the main cause of mortality. According to the Robert Koch Institute (RKI) and the German Federal Statistical office:
about 40% of deaths in Germany to go back to cardio‑ vascular diseases;
the highest mortality rate is recorded in the case of persons over the age of 65 years;
Men in most age groups have a higher mortality rate than women, which is partly explained by the different life-style factors and biological differences.
The main causes and risk factors
Among the most common causes of death in the context of CVD:
Heart Attack (Myocardial Infarction);
Stroke (Cerebral Stroke);
Heart Failure (Congestive Heart Failure);
arrhythmic deaths.
The most important modifiable risk factors include:
arterial hypertension;
Hyperlipidemia;
Diabetes mellitus type 2;
Tobacco consumption;
lack of physical activity;
unhealthy diet;
Overweight and obesity.
Non-modifiable risk factors are:
Age;
Gender;
family history of early cardiovascular disease.
Trends and developments
Despite progress in diagnostics and therapy, the absolute number of deaths by heart disease, which is influenced mainly by the ageing of the population. At the same time, age standardization of death rates shows a declining Trend:
since the 1980s, the standardised death rate decreased due to cardiovascular diseases in Germany, more than 50%;
this is due to the improvement of medical care, the introduction of prevention programs and the reduction of risk factors (e.g., the reduction of tobacco consumption).
Prevention and Intervention
An effective reduction of the mortality requires a Multi‑level approach:
Primary prevention: education on healthy lifestyle, blood pressure and cholesterol Screening, vaccination (for example, against the flu to avoid complications in high-risk patients).
Secondary prevention: early diagnosis and continuous therapy in the case of already existing diseases (e.g., use of medication after a heart attack).
Health policy: a legal measures to reduce the consumption of tobacco, salt and sugar reduction in food that promote movement in the cities.
Conclusion
The mortality by diseases of the circulatory system in Germany, a Central challenge for the health, although the standardized mortality rates have been falling for decades. A sustainable reduction requires the development of prevention strategies, the strengthening of health education and improving access to medical care for all population groups. The control of risk factors at the individual and societal level is the key to further reduction in cardiovascular mortality.
Would you like me to make a certain section in greater detail or further data and sources to add?
- [x] <a href="http://mitroc.com/userfiles/5687-cardiovascular-disease-pressure.xml">The mortality due to diseases of the circulatory System</a>
- [x] <a href="http://www.magiclashes.cz/files/8461-cardiovascular-biology.xml">Results Of Cardiovascular Diseases</a>
- [x] <a href="http://spolecenskysalon.cz/files/increase-in-cardiovascular-diseases-1615.xml">Cardio Balance against high blood pressure</a>
- [x] <a href="http://artikos.pl/userfiles/cardiovascular-disease-groups.xml">http://artikos.pl/userfiles/cardiovascular-disease-groups.xml</a>
<a href="https://pad.nantes.cloud/s/vFigD2SXrd">https://pad.nantes.cloud/s/vFigD2SXrd</a>
<a href="https://codi.sevenvm.de/s/lgBAYojmr">https://codi.sevenvm.de/s/lgBAYojmr</a>
<a href="https://md.giplt.nl/s/IezXdwcdZg">https://md.giplt.nl/s/IezXdwcdZg</a>
<a href="https://pad.hxx.cz/s/3XChcCBoh6">https://pad.hxx.cz/s/3XChcCBoh6</a>
<a href="https://md.nolog.cz/s/DSKY08XfY">https://md.nolog.cz/s/DSKY08XfY</a>
<a href="https://edit.leiden.digital/s/puR-3RzGki">https://edit.leiden.digital/s/puR-3RzGki</a>
<a href="https://pad.mytga.de/s/6AAHfFChm">https://pad.mytga.de/s/6AAHfFChm</a>
<a href="https://md.interhacker.space/s/8D_-_-jgY">https://md.interhacker.space/s/8D_-_-jgY</a>
<a href="https://hd.wedler.me/s/CoMfhzr6c">https://hd.wedler.me/s/CoMfhzr6c</a>
<a href="https://docs.localcharts.org/s/pak8qX4bZ">https://docs.localcharts.org/s/pak8qX4bZ</a>
<a href="https://hedgedoc.stanleysolutionsnw.com/s/09uBbWT1IX">https://hedgedoc.stanleysolutionsnw.com/s/09uBbWT1IX</a>
<a href="https://md.coredump.ch/s/fXq-1ui1-">https://md.coredump.ch/s/fXq-1ui1-</a>
<a href="https://pad.sra.uni-hannover.de/s/pr42qV4Psi">https://pad.sra.uni-hannover.de/s/pr42qV4Psi</a>
<a href="https://doc.fung.uy/s/ONquJTvguy">https://doc.fung.uy/s/ONquJTvguy</a>
<a href="https://pad.fablab-siegen.de/s/eQfzFamYER">https://pad.fablab-siegen.de/s/eQfzFamYER</a>
<a href="https://md.sigma2.no/s/6H-1ExRcu">https://md.sigma2.no/s/6H-1ExRcu</a>
<a href="https://md.sebastians.dev/s/AGsmaC_Rg">https://md.sebastians.dev/s/AGsmaC_Rg</a>
<a href="https://pads.cantorgymnasium.de/s/h0Mzbr1Kh">https://pads.cantorgymnasium.de/s/h0Mzbr1Kh</a>
<a href="https://write.frame.gargantext.org/s/rkTmsEazMl">https://write.frame.gargantext.org/s/rkTmsEazMl</a>
<a href="https://md.gafert.org/s/xF72XZSWj">https://md.gafert.org/s/xF72XZSWj</a>
<a href="https://hedgedoc.digilol.net/s/PHPu4JuxQ3">https://hedgedoc.digilol.net/s/PHPu4JuxQ3</a>
<a href="https://hedgedoc.auro.re/s/yBtperRFFn">https://hedgedoc.auro.re/s/yBtperRFFn</a>
<a href="https://hedgedoc.private.coffee/s/5FspUXbvo">https://hedgedoc.private.coffee/s/5FspUXbvo</a>
<a href="https://hackmd.hub.yt/s/emUjCer0Y">https://hackmd.hub.yt/s/emUjCer0Y</a>
<a href="https://pad.cttue.de/s/SHktiZ6C-">https://pad.cttue.de/s/SHktiZ6C-</a>
<a href="https://pad.data.coop/s/-GCsh08vb">https://pad.data.coop/s/-GCsh08vb</a>
<a href="https://md.rappet.xyz/s/8ksfQa-I2I">https://md.rappet.xyz/s/8ksfQa-I2I</a>
<a href="https://doc.hkispace.com/s/bU_xY7QOM">https://doc.hkispace.com/s/bU_xY7QOM</a>
<a href="https://hedgedoc.stusta.de/s/scVqcuozv">https://hedgedoc.stusta.de/s/scVqcuozv</a>
<a href="https://md.mandragot.org/s/XzHG8B4xxm">https://md.mandragot.org/s/XzHG8B4xxm</a>
<a href="https://pad.medialepfade.net/s/xX4JTCXBL">https://pad.medialepfade.net/s/xX4JTCXBL</a>
<a href="https://hedgedoc.syyrell.com/s/taYPrlm6d1">https://hedgedoc.syyrell.com/s/taYPrlm6d1</a>
<a href="https://pad.flipdot.org/s/FW5JqgzRyx">https://pad.flipdot.org/s/FW5JqgzRyx</a>
<a href="https://pad.geolab.space/s/c0bNqxJzT6">https://pad.geolab.space/s/c0bNqxJzT6</a>
<a href="https://hackmd.openmole.org/s/-HXoCEmyM">https://hackmd.openmole.org/s/-HXoCEmyM</a>
<a href="https://pad.deckenpfronn.info/s/vU5X8Z4Hr">https://pad.deckenpfronn.info/s/vU5X8Z4Hr</a>
<a href="https://notes.simeonreusch.com/s/u3k963xRb">https://notes.simeonreusch.com/s/u3k963xRb</a>
<a href="https://md.infs.ch/s/8aV9B4l7q3">https://md.infs.ch/s/8aV9B4l7q3</a>
<a href="https://hack.utopia-lab.org/s/0-aaCTe-1">https://hack.utopia-lab.org/s/0-aaCTe-1</a>
<a href="https://pad.koeln.ccc.de/s/vO4rlvBd8">https://pad.koeln.ccc.de/s/vO4rlvBd8</a>
<a href="https://hedgedoc.obco.pro/s/i150BpHWl">https://hedgedoc.obco.pro/s/i150BpHWl</a>
<a href="https://pad.multiplace.org/s/r1TnTE6zfe">https://pad.multiplace.org/s/r1TnTE6zfe</a>
<a href="https://notes.stuve.fau.de/s/_WoBwg0vhb">https://notes.stuve.fau.de/s/_WoBwg0vhb</a>
<a href="https://hedgedoc.inqbus.de/s/y8KwkK_hb">https://hedgedoc.inqbus.de/s/y8KwkK_hb</a>
<a href="https://omoffice.de/s/BkI6aV6ffe">https://omoffice.de/s/BkI6aV6ffe</a>
<a href="https://hedgedoc.nrp-nautilus.io/s/wdJ4EULpbU">https://hedgedoc.nrp-nautilus.io/s/wdJ4EULpbU</a>
<a href="https://pad.darmstadt.social/s/MXeces0fVt">https://pad.darmstadt.social/s/MXeces0fVt</a>
<a href="https://hedgedoc.faimaison.net/s/k_CaSJEtTT">https://hedgedoc.faimaison.net/s/k_CaSJEtTT</a>
<a href="https://hedgedoc.team23.org/s/Teo9rOw8ts">https://hedgedoc.team23.org/s/Teo9rOw8ts</a>
<a href="https://pad.eisfunke.com/s/F7ItedcNQL">https://pad.eisfunke.com/s/F7ItedcNQL</a>
<a href="https://hedgedoc.eclair.ec-lyon.fr/s/s4Xk8fK7B">https://hedgedoc.eclair.ec-lyon.fr/s/s4Xk8fK7B</a>
<a href="https://pad.stuve.de/s/_9zSIx2XN">https://pad.stuve.de/s/_9zSIx2XN</a>
<a href="https://text.fraction.jp/s/J2ktcQZL2">https://text.fraction.jp/s/J2ktcQZL2</a>
<a href="https://pad.ccc-p.org/s/uC5fza0bZd">https://pad.ccc-p.org/s/uC5fza0bZd</a>
<a href="https://doc.hkispace.com/s/yHzgBMORc">https://doc.hkispace.com/s/yHzgBMORc</a>
<a href="https://hd.platypwnies.de/s/qv3okOmZCN">https://hd.platypwnies.de/s/qv3okOmZCN</a>
<a href="https://pads.dgnum.eu/s/ZIrrwQEsC8">https://pads.dgnum.eu/s/ZIrrwQEsC8</a>
<a href="https://doc.cisti.org/s/y4-6SKPhpD">https://doc.cisti.org/s/y4-6SKPhpD</a>
<a href="https://pad.demokratie-dialog.de/s/JgddLych-J">https://pad.demokratie-dialog.de/s/JgddLych-J</a>
<a href="https://pad.wolkenbar.de/s/Ev4rw4IyqB">https://pad.wolkenbar.de/s/Ev4rw4IyqB</a>
<a href="https://md.chaosdorf.de/s/UtnOO4YB8U">https://md.chaosdorf.de/s/UtnOO4YB8U</a>
<a href="https://md.globenet.org/s/FwnDLYv0H">https://md.globenet.org/s/FwnDLYv0H</a>
<a href="https://doc.spiegie.de/s/NQlhOdBwl">https://doc.spiegie.de/s/NQlhOdBwl</a>
<a href="https://md.eris.cc/s/KcDRVhTxcE">https://md.eris.cc/s/KcDRVhTxcE</a>
<a href="https://notas.gaiacoop.tech/s/Hekj8Q5bk">https://notas.gaiacoop.tech/s/Hekj8Q5bk</a>
## Cardio Balance against high blood pressure ##
Vitafon against hypertension: An analysis of the potential impact
High blood pressure (arterial hypertension) represents a worldwide health problem that is associated with an increased risk for cardiovascular disease, strokes, and kidney damage. In the search for additional treatment options of invasive and non‑pharmacological approaches increasingly gain in importance. Such a device is discussed in this context, the Vitafon — a device for vibro-acoustic therapy.
Principle of vibro-acoustic therapy
The Vitafon uses the method of vibro-acoustic Stimulation, the gentle vibrations with specific frequencies (20-20000 Hz) affect the body. These vibrations are:
the micro-circulation of blood and lymph fluid to improve;
the relaxation of the smooth muscles of the blood vessels, promote;
the metabolism in the tissues to stimulate;
the General relaxation and stress reduction support.
Potential mechanisms of action against high blood pressure
The hand of the above-mentioned effects, the application of the Vitafons the following positive effects on patients with high blood pressure:
Vascular extension. Through the Stimulation of micro-circulation and the relaxation of the vascular wall, a smooth blood pressure-lowering could be achieved in the effect.
Improved Renal Function. Optimized blood flow to the kidney can affect the Regulation of blood pressure by the Renin‑Angiotensin‑aldosterone System to be positive.
Stress reduction. The relaxing effect of the vibration can reduce the Sympathikuston, which leads to a decrease in peripheral vascular resistance.
The reduction of pain. In patients in whom chronic pain contribute to the elevated blood pressure can result in pain relief through therapy, indirectly, to a normalization of blood pressure.
Clinical evidence and research
It is important to emphasize that the scientific evidence for the effectiveness of the Vitafons in hypertension is currently limited. Previous studies have the following characteristics:
Small samples: a Lot of studies have been conducted with a small number of participants.
Lack of randomization: It is controlled, randomized clinical trials investigating the effectiveness compared with a Placebo group are missing.
Heterogeneous study design: The different protocols for the application of the duration and frequency complicate a direct comparison of the results.
Some pilot studies, however, report a moderate reduction in systolic and diastolic blood pressure after several weeks of regular application. The observed effects were in the range of 5-15 mmHg.
Conclusions and recommendations
The Vitafon can not be considered as a complementary method in the treatment of high blood pressure into consideration, however, as a replacement for conventional therapy. Patients should talk to before the beginning of such a therapy with your doctor.
Future research should focus on the implementation of larger, randomized, and controlled studies of the efficacy and safety of the vibro-acoustic therapy for arterial hypertension to assess.
Glossary:
High blood pressure — blood pressure values above the normal range (≥140/90 mmHg).
Arterial hypertension — the medical term for high blood pressure.
Microcirculation blood flow at the level of capillaries and small vessels.
Renin‑Angiotensin‑aldosterone System, a hormone system that regulates blood pressure and water‑electrolyte balance.
Sympathikuston — activity of the autonomic nervous system, which can increase blood pressure.
Would you like me to make a certain section in more detail or additional information to add?
<a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">Cardiovascular Disease Risk</a>